Birin, Axl P.

HRN: 24-97-16  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/15/2024
11/22/2024
INTRAVENOUS
75 Mg IV
Q24H
PCAP-C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: